Increased Frequency of Autism by Previous Diagnosis and Screening in Children with Fetal-Neonatal Alloimmune Thrombocytopenia (FNAIT) with and without an Intracranial Hemorrhage (ICH).
Katherine A Knightly, Eleanore A McFarland, Emilie Vander Haar, Margaret H McKelvy, Thea D Palmer, Stephanie V Volpe, Stacy Corke, James B Bussel
{"title":"Increased Frequency of Autism by Previous Diagnosis and Screening in Children with Fetal-Neonatal Alloimmune Thrombocytopenia (FNAIT) with and without an Intracranial Hemorrhage (ICH).","authors":"Katherine A Knightly, Eleanore A McFarland, Emilie Vander Haar, Margaret H McKelvy, Thea D Palmer, Stephanie V Volpe, Stacy Corke, James B Bussel","doi":"10.1016/j.ajog.2025.06.052","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Fetal-Neonatal AlloImmune Thrombocytopenia (FNAIT) results from parental platelet antigen incompatibility and maternal alloimmunization, most commonly to platelet antigen HPA-1a. De Vos et al. identified mild-moderate neurologic injury in 26% of 31 FNAIT-affected children aged 6-14 without past ICH. Suspicions from NAITbabies members, along with the De Vos observations, led to a survey evaluation of autism in FNAIT-affected children.</p><p><strong>Objective(s): </strong>This study explored the frequency of autism both by previous diagnosis and by screening in FNAIT-affected children with and without having had an ICH.</p><p><strong>Study design: </strong>A de-identified survey was made available to mothers in NAITbabies, assessing risk of autism using four age-specific autism screening scales: Q-CHAT-10 for ages 18-24 months (n=18); M-CHAT-R 2-4 years(n=61); AQ-10-Child 4 -11 years (n=175); and AQ-10-Adolescent for >12 years (n=66). Mothers reported their child's ICH status and pre-screening autism diagnoses. Survey responses were scored using specific questionnaire algorithms.</p><p><strong>Results: </strong>Among 320 FNAIT-affected children, 24 (7.5%) had a previous autism diagnosis and 64 (20%) screened at risk. Among 182 children with known ICH status, that could be linked to an autism questionnaire response, 33 had suffered an ICH and 149 had not. Both pre-existing and screening autism diagnoses increased with age in both ICH and non-ICH groups, peaking in the 12+ age group: 67% with ICH and 36% without ICH. Autism findings were higher among ICH children but were most striking in the non-ICH group. 7.5% of the 4-11 age group (no ICH) and 18% of the 12+ age group (no ICH) already had been diagnosed with autism. With screening for high risk of autism, these numbers more than doubled to 19% (4-11 age group) and 36% (12+ age group). Positive predictive values of the latter two questionnaires were 0.94 and 0.86, respectively.</p><p><strong>Conclusions: </strong>In FNAIT-affected children without an ICH, rates of autism were surprisingly high and became more apparent with age. These findings highlight the need for early screening and ongoing careful monitoring of children affected by FNAIT, even without known ICH, who can no longer be considered \"consequence-free.\"</p>","PeriodicalId":7574,"journal":{"name":"American journal of obstetrics and gynecology","volume":" ","pages":""},"PeriodicalIF":8.7000,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of obstetrics and gynecology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ajog.2025.06.052","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Fetal-Neonatal AlloImmune Thrombocytopenia (FNAIT) results from parental platelet antigen incompatibility and maternal alloimmunization, most commonly to platelet antigen HPA-1a. De Vos et al. identified mild-moderate neurologic injury in 26% of 31 FNAIT-affected children aged 6-14 without past ICH. Suspicions from NAITbabies members, along with the De Vos observations, led to a survey evaluation of autism in FNAIT-affected children.
Objective(s): This study explored the frequency of autism both by previous diagnosis and by screening in FNAIT-affected children with and without having had an ICH.
Study design: A de-identified survey was made available to mothers in NAITbabies, assessing risk of autism using four age-specific autism screening scales: Q-CHAT-10 for ages 18-24 months (n=18); M-CHAT-R 2-4 years(n=61); AQ-10-Child 4 -11 years (n=175); and AQ-10-Adolescent for >12 years (n=66). Mothers reported their child's ICH status and pre-screening autism diagnoses. Survey responses were scored using specific questionnaire algorithms.
Results: Among 320 FNAIT-affected children, 24 (7.5%) had a previous autism diagnosis and 64 (20%) screened at risk. Among 182 children with known ICH status, that could be linked to an autism questionnaire response, 33 had suffered an ICH and 149 had not. Both pre-existing and screening autism diagnoses increased with age in both ICH and non-ICH groups, peaking in the 12+ age group: 67% with ICH and 36% without ICH. Autism findings were higher among ICH children but were most striking in the non-ICH group. 7.5% of the 4-11 age group (no ICH) and 18% of the 12+ age group (no ICH) already had been diagnosed with autism. With screening for high risk of autism, these numbers more than doubled to 19% (4-11 age group) and 36% (12+ age group). Positive predictive values of the latter two questionnaires were 0.94 and 0.86, respectively.
Conclusions: In FNAIT-affected children without an ICH, rates of autism were surprisingly high and became more apparent with age. These findings highlight the need for early screening and ongoing careful monitoring of children affected by FNAIT, even without known ICH, who can no longer be considered "consequence-free."
期刊介绍:
The American Journal of Obstetrics and Gynecology, known as "The Gray Journal," covers the entire spectrum of Obstetrics and Gynecology. It aims to publish original research (clinical and translational), reviews, opinions, video clips, podcasts, and interviews that contribute to understanding health and disease and have the potential to impact the practice of women's healthcare.
Focus Areas:
Diagnosis, Treatment, Prediction, and Prevention: The journal focuses on research related to the diagnosis, treatment, prediction, and prevention of obstetrical and gynecological disorders.
Biology of Reproduction: AJOG publishes work on the biology of reproduction, including studies on reproductive physiology and mechanisms of obstetrical and gynecological diseases.
Content Types:
Original Research: Clinical and translational research articles.
Reviews: Comprehensive reviews providing insights into various aspects of obstetrics and gynecology.
Opinions: Perspectives and opinions on important topics in the field.
Multimedia Content: Video clips, podcasts, and interviews.
Peer Review Process:
All submissions undergo a rigorous peer review process to ensure quality and relevance to the field of obstetrics and gynecology.